PSMA2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.245000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.256600E-01
Normal-vs-Stage2
6.883600E-01
Normal-vs-Stage3
9.069200E-01
Normal-vs-Stage4
6.432800E-01
Stage1-vs-Stage2
2.814600E-01
Stage1-vs-Stage3
8.759800E-01
Stage1-vs-Stage4
3.356400E-01
Stage2-vs-Stage3
5.073400E-01
Stage2-vs-Stage4
9.512600E-01
Stage3-vs-Stage4
6.700000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.549000E-01
Normal-vs-AfricanAmerican
3.094600E-01
Normal-vs-Asian
6.980000E-01
Caucasian-vs-AfricanAmerican
5.986200E-01
Caucasian-vs-Asian
7.370400E-01
AfricanAmerican-vs-Asian
8.350600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.816600E-01
Normal-vs-Female
6.597400E-01
Male-vs-Female
4.436200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.437400E-01
Normal-vs-Age(41-60Yrs)
3.399600E-01
Normal-vs-Age(61-80Yrs)
9.440200E-01
Normal-vs-Age(81-100Yrs)
4.474600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.689370E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.360000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.725800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.921000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.819000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.119600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.537200E-01
Normal-vs-Daily Drinker
9.473400E-01
Normal-vs-Weekly Drinker
9.016800E-01
Normal-vs-Occasional Drinker
3.037200E-01
Normal-vs-Social Drinker
5.608000E-01
Non Drinker-vs-Daily Drinker
7.942000E-01
Non Drinker-vs-Weekly Drinker
7.105000E-01
Non Drinker-vs-Occasional Drinker
2.044500E-02
Non Drinker-vs-Social Drinker
3.491000E-01
Daily Drinker-vs-Weekly Drinker
8.729200E-01
Daily Drinker-vs-Occasional Drinker
4.934200E-02
Daily Drinker-vs-Social Drinker
5.066800E-01
Weekly Drinker-vs-Occasional Drinker
1.709040E-01
Weekly Drinker-vs-Social Drinker
7.463800E-01
Occasional Drinker-vs-Social Drinker
1.337770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.776200E-01
Normal-vs-Grade 2
9.377000E-01
Normal-vs-Grade 3
9.858600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.719570E-01
Grade 1-vs-Grade 3
2.348300E-02
Grade 1-vs-Grade 4
8.776200E-01
Grade 2-vs-Grade 3
1.192970E-01
Grade 2-vs-Grade 4
9.377000E-01
Grade 3-vs-Grade 4
9.858600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.956200E-01
Normal-vs-NonDiabetic
6.553400E-01
Diabetic-vs-NonDiabetic
1.573170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.145600E-01
Normal-vs-NoPancreatitis
7.449200E-01
Pancreatitis-vs-NoPancreatitis
9.519400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.277400E-01
Normal-vs-N1
6.808000E-01
N0-vs-N1
3.987000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.651370E-01
Normal-vs-TP53-NonMutant
9.376600E-01
TP53-Mutant-vs-TP53-NonMutant
1.93449999996709E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
